|
Name: Butonitazene (2-(2-(4-butoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine)
Type: Opioid analgesic
AKA: N/A
|
|
II. Natural Derivative
Synthetic substance, no natural derivative
 |
|
III. Chemical Profile (IUPAC name)
|
|
IV. History
Butonitazene is a synthetic opioid analgesic that was first developed in the mid-20th century. It is part of the benzimidazole class of opioids, which includes several other potent pain-relievers. Butonitazene is not widely used medically and is primarily found in research settings. Due to its high potency and risk of overdose, it has been the subject of regulation and control to prevent misuse.
|
|
V. Legal Information
Butonitazene is a synthetic opioid with limited historical use and regulation. It is not specifically scheduled under most national drug control laws but may be covered under analog or general controlled substance regulations due to its opioid properties. In the US, it could be regulated under the Federal Analogue Act if deemed similar to controlled substances. Its legal status is less defined compared to more well-known opioids, resulting in varying regulations by region.
US Federal Schedule - I
Schedule I drugs, substances, or chemicals are defined as drugs with no currently accepted medical use and a high potential for abuse. Some examples of Schedule I drugs are: heroin, lysergic acid diethylamide (LSD), marijuana (cannabis), 3,4-methylenedioxymethamphetamine (ecstasy), methaqualone, and peyote.
Key US Federal Policies:
Controlled Substances Act. Public Law: Public Law 91-513 (text can be found on GovInfo) (https://www.dea.gov/drug-information/csa). Date enacted: October 27, 1970.
|
|
VI. Physical Effects
Butonitazene is a potent synthetic opioid known for its strong analgesic effects. As a downer, it depresses the central nervous system, which can lead to reduced heart rate and respiratory depression. Short-term effects include sedation and pain relief, while long-term use may result in severe addiction, tolerance, and overdose risks. Safe use is challenging due to its high potency and potential for addiction. Overdose can be fatal due to respiratory depression. Recent research highlights its potential for misuse and the need for careful regulation.  |
|
VII. Psychological Effects
Butonitazene, a synthetic opioid, affects the brain's opioid receptors, leading to euphoria and pain relief. Its psychological effects can include mood swings, anxiety, and impaired cognition. The substance's effects can last several hours, with risks of long-term psychological dependence and cognitive impairment. Research into its specific psychological impacts is limited but growing.
 |
|
VIII. Culture
Butonitazene, a synthetic opioid, has less historical and cultural lore compared to more established opioids like morphine. Emerging in the 21st century, it is primarily known in the context of the opioid epidemic. Its potent analgesic properties make it a subject of concern for public health officials due to its potential for abuse and overdose. The cultural narrative around butonitazene is intertwined with the broader opioid crisis, reflecting ongoing societal challenges in balancing pain management and drug misuse. It highlights the tensions in modern medicine and law enforcement efforts to curb the spread of synthetic opioids.
 |